Chester County News and Community Website
Despite lung cancer being the leading cause of cancer deaths in the United States, a new survey shows that many Americans are unaware of their risk for the disease and …
Only 40% of Americans Concerned About Lung Cancer: Survey Shows Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that clinical data from its Phase 3 ROMAN trial of avasopasem for severe oral mucositis will be presented in an oral …
Galera to Present at 2022 American Society of Clinical Oncology Annual Meeting Read More
CONSHOHOCKEN, PA — AmerisourceBergen recently announced that it is now offering Prime Therapeutics’ IntegratedRx™ – Oncology program to eligible hospital, health system and independent oncology practice customers. Prime Therapeutics (Prime) is a pharmacy …
AmerisourceBergen to Now Offer Prime Therapeutics’ IntegratedRx – Oncology to Eligible Hospital, Health System & Oncology Practice Customers Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that the Company will host a virtual Key Opinion Leader event on radiotherapy-induced severe oral mucositis (SOM) in patients with head …
Galera to Host Virtual Key Opinion Leader Event on Radiotherapy-Induced Severe Oral Mucositis (SOM) in Patients with Head and Neck Cancer Read More
MALVERN, PA — Representative Chrissy Houlahan (D-PA) on Wednesday joined Novocure leadership to tour their Malvern facility and learn more about their vital work. There, she heard about their mission …
Houlahan Tours Leading Cancer Treatment Development Facility Novocure, Meets with Malvern Employees Read More
PLYMOUTH MEETING, PA — Among all patients with neuroendocrine tumors (NETs), the risk of dying of cancer was higher than that of dying of other causes, but mortality varies by primary …
JNCCN Study Reveals Neuroendocrine Tumor Mortality Patterns to Inform Treatment Decisions Read More
CHEYNEY, PA — Navrogen Inc. and Tavotek Biotherapeutics announced today that they have entered into a strategic collaboration to identify and develop experimental monoclonal antibodies (mAbs) for the treatment of …
Navrogen Inc. and Tavotek Biotherapeutics Announce Strategic Collaboration Read More
WASHINGTON, D.C. — The following quote is attributed to Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in …
FDA Provides Guidance on Measuring Patient-Reported Outcomes in Cancer Clinical Trials Read More
MALVERN PA — HMP Global, a leading healthcare event and education company, announced the agenda and faculty lineup for its inaugural Great Debates & Updates in Women’s Oncology, taking place …
HMP Global Announces Distinguished Faculty Lineup for Inaugural Great Debates & Updates in Women’s Oncology Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults …
FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy Read More